By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NeuroVive Pharmaceutical AB 

Biomedical Center

Sölvegatan 19    SE-221 84 Lund  Sweden
Phone: 46-0-46-288-0110 Fax: 46-0-46-888-8348



Company News
NeuroVive (NVP) Chief Executive Brönnegârd Replaced After Stocks Tank and Clinical Trial Falters 9/1/2015 6:52:06 AM
NeuroVive Discontinues Ciclomulsion for Myocardial Infarction 8/31/2015 6:26:46 AM
NeuroVive Share upgraded On OTC Market In U.S. 6/26/2015 2:25:26 PM
NeuroVive: Neurovive Reports Topline Results Of Phase III CIRCUS Study In Acute Myocardial Infarction 6/1/2015 11:19:22 AM
NeuroVive (Publ) - Amendment Number Of Shares And Votes 5/29/2015 1:05:08 PM
NeuroVive Asia Signs Collaboration Agreement With Sanofi (SAN.PA) For The Development And Commercialization Of Ciclomulsion In South Korea 5/26/2015 11:07:21 AM
NeuroVive: Topline Result Of Phase III Study Of Ciclomulsion In Acute Myocardial Infarction Expected This Quarter 5/26/2015 10:51:07 AM
NeuroVive: Interim Report 1 Jan. 2015 Till 31 Mar. 2015 5/20/2015 12:02:48 PM
NeuroVive: NeuroVive Announces Prospectus Regarding Admission To Trading Of New Shares 5/19/2015 1:17:38 PM
NeuroVive: Published Data Indicates Protective Effect Of Cyclosporine In Patients With Stroke 5/7/2015 11:00:34 AM